Patents by Inventor Lisa Nannizzi Alaimo

Lisa Nannizzi Alaimo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of integrin-mediated signal transduction
    Publication number: 20030059852
    Abstract: The present invention discloses that phosphorylation of cytoplasmic tyrosine residues in the &bgr;-subunit of integrins is needed for signal protein association. The invention provides methods of identifying signaling partners involved in integrin mediated signaling, methods of identifying agents which block integrin mediated signaling, methods of using agents which block integrin mediated signaling to modulate biological and pathological processes, and agents which block integrin mediated signaling.
    Type: Application
    Filed: March 8, 2001
    Publication date: March 27, 2003
    Applicant: COR Therapeutics, Inc.
    Inventors: David R. Phillips, Deborah Ann Law, Lisa Nannizzi Alaimo
  • Modulation of integrin-mediated signal transduction
    Patent number: 6210913
    Abstract: The present invention discloses that phosphorylation of cytoplasmic tyrosine residues in the &bgr;-subunit of integrins is needed for signal protein association. The invention provides methods of identifying signaling partners involved in integrin mediated signaling, methods of identifying agents which block integrin mediated signaling, methods of using agents which block integrin mediated signaling to modulate biological and pathological processes, and agents which block integrin mediated signaling.
    Type: Grant
    Filed: October 18, 1996
    Date of Patent: April 3, 2001
    Assignee: COR Therapeutics, Inc.
    Inventors: David R. Phillips, Deborah Ann Law, Lisa Nannizzi Alaimo